Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
清热强腰颗粒与柳氮磺吡啶对照治疗强直性脊柱炎(湿热痹阻、肝肾亏虚证)随机、双盲双模拟、多中心临床试验
[Translation] A randomized, double-blind, double-dummy, multicenter clinical trial comparing Qingre Qiangyao granules with sulfasalazine in the treatment of ankylosing spondylitis (damp-heat obstruction, liver and kidney deficiency syndrome)
以柳氮磺吡啶对照,初步评价清热强腰颗粒治疗强直性脊柱炎(湿热痹阻、肝肾亏虚证)的安全性、有效性.
[Translation] The safety and efficacy of Qingre Qiangyao Granule in the treatment of ankylosing spondylitis (damp-heat obstruction, liver and kidney deficiency syndrome) were preliminarily evaluated by comparing with sulfasalazine.
100 Clinical Results associated with Beijing Jiayu Dexing Pharmaceutical Technology Development Co., Ltd.
0 Patents (Medical) associated with Beijing Jiayu Dexing Pharmaceutical Technology Development Co., Ltd.
100 Deals associated with Beijing Jiayu Dexing Pharmaceutical Technology Development Co., Ltd.
100 Translational Medicine associated with Beijing Jiayu Dexing Pharmaceutical Technology Development Co., Ltd.